BridgeMD
New treatment option for Heart Failure
Official title VIrtual Care To Improve Outcomes and RecoverY From Heart Failure Hospitalization
ClinicalTrials.gov ID: NCT05724433
What this study is testing
- What it's testing
- The clinic visits (intervention) will continue for 90 days, which represents the follow-up period for the primary medication and health status outcomes. The co-primary clinical outcomes will be obtained at 180 days.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adult patients ≥ 18 years old who:
- Are being discharged after hospitalization or urgent visit for HF as
- a primary diagnosis or
- significant complication (prolonging length of stay) of another diagnosis OR Have been referred for an initial consult at a cardiology clinic within...
- Have left ventricular ejection fraction (LVEF) \< 50% within the preceding 3 months.
You likely can't join if
- Died or left hospital before medically advised hospital discharge
- Unable to self-assess or communicate symptoms (e.g. clinically evident dementia)
- Unable to engage with digital health technology or follow up
- Severe valve disease
- Recipient of or on waiting list for LVAD or cardiac transplant
- Complex congenital heart disease, hypertrophic obstructive cardiomyopathy, or amyloid cardiomyopathy
See the full eligibility criteria
- Adult patients ≥ 18 years old who:
- Are being discharged after hospitalization or urgent visit for HF as
- a primary diagnosis or
- significant complication (prolonging length of stay) of another diagnosis OR Have been referred for an initial consult at a cardiology clinic within 1 week of hospitalization or urgent visit for HF as a primary or...
- Have left ventricular ejection fraction (LVEF) \< 50% within the preceding 3 months.
- Have NT-proBNP of \> 900 pg/ml during hospital admission or within 7 days after discharge from the ED
- Have a mailing address for patient or caregiver
- Provide verbal consent
- Died or left hospital before medically advised hospital discharge
- Unable to self-assess or communicate symptoms (e.g. clinically evident dementia)
- Unable to engage with digital health technology or follow up
- Severe valve disease
- Recipient of or on waiting list for LVAD or cardiac transplant
- Complex congenital heart disease, hypertrophic obstructive cardiomyopathy, or amyloid cardiomyopathy
- Severe lung disease with symptoms on minimal exertion, forced expiratory volume during 1 second (FEV1) \ 60 mm Hg, or on home oxygen
- Severe kidney disease (persistent eGFR \< 30 mL/min/1.73m2)
- Active malignancy
- Receiving palliative care or expected life expectancy \< 6 months
The study team makes the final eligibility decision.
Where it's taking place
- Hamilton, Onatrio, Canada
- Hamilton, Ontario, Canada
- Thunder Bay, Ontario, Canada
- Toronto, Ontario, Canada
- Monastir, Tunisia
- Sfax, Tunisia
- Sousse, Tunisia
- Tunis, Tunisia
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hamilton, Onatrio, Canada; Hamilton, Ontario, Canada; Thunder Bay, Ontario, Canada; Toronto, Ontario, Canada; Monastir, Tunisia; Sfax, Tunisia and 2 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.